Above, we have established that, with a substantial degree of certainty, iAβ depletion therapy, via the activation of BACE1 and/or BACE2 or otherwise, would be highly effective in the prevention of conventional AD, when the AβPP-independent iAβ generation pathway is inoperative. Here, BACE2 is linked to Alzheimer disease.